Skip to content

Effect of serotonin-norepinephrine reuptake inhibitor on functional gastrointestinal disorder and evaluation of the brain function.

Effect of serotonin-norepinephrine reuptake inhibitor on functional gastrointestinal disorder and evaluation of the brain function. - Effect of SNRI on functional gastrointestinal disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023995
Enrollment
200
Registered
2016-09-09
Start date
2015-12-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional gastrointestinal disorder

Interventions

The patients in functionality gastrointestinal disease throw duloxetine 20mg to average treatment for 6 weeks. The patients in functionality gastrointestinal disease throw PURASEBO to average treatmen

Sponsors

Shimane University Faculty of Medicine Department of Psychiatry
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Agreement by a document can be acquired from the patient who didn't also admit improvement of the symptom using a curative for the first step which appears on a guideline by functionality dyspepsia or hypersensitive gut syndrome and a checked case from the symptom and an examination in endoscope.

Exclusion criteria

Exclusion criteria: The case which isn't treated by other anti-depressants. The case with the medical history of the hyperesthesia. The case which merges the disease judged to have an influence on the life of the patient. The case with which I participated in other clinical trials and clinical tests within 6 months before experimental drug prescription.

Design outcomes

Primary

MeasureTime frame
PAGI-SYM:The change in the general score and the lower rank score of PAGI-SYM between a baseline and 6 weeks later of prescription.

Countries

Japan

Contacts

Public ContactRei Wake

Shimane University Faculty of Medicine Department of Psychiatry

rei@med.shimane-u.ac.jp0853-23-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026